120 related articles for article (PubMed ID: 2406830)
1. Nonhematologic toxicities of selected chemotherapeutic agents used in the treatment of adult leukemia.
Cunningham M
Semin Oncol Nurs; 1990 Feb; 6(1):67-75. PubMed ID: 2406830
[No Abstract] [Full Text] [Related]
2. Sequential pilot studies of intensive postremission chemotherapy for acute nonlymphocytic leukemia.
Petti MC; Avvisati G; Tafuri A; Meloni G; Amadori S; Mandelli F
Ann N Y Acad Sci; 1987; 511():436-41. PubMed ID: 3326472
[No Abstract] [Full Text] [Related]
3. Induction chemotherapy for acute myelogenous leukemia.
Kalaycio M
Curr Hematol Rep; 2005 Jan; 4(1):49-50. PubMed ID: 15610659
[No Abstract] [Full Text] [Related]
4. High-dose cytarabine consolidation with or without additional amsacrine and mitoxantrone in acute myeloid leukemia: results of the prospective randomized AML2003 trial.
Schaich M; Parmentier S; Kramer M; Illmer T; Stölzel F; Röllig C; Thiede C; Hänel M; Schäfer-Eckart K; Aulitzky W; Einsele H; Ho AD; Serve H; Berdel WE; Mayer J; Schmitz N; Krause SW; Neubauer A; Baldus CD; Schetelig J; Bornhäuser M; Ehninger G
J Clin Oncol; 2013 Jun; 31(17):2094-102. PubMed ID: 23630210
[TBL] [Abstract][Full Text] [Related]
5. Treatment of relapsed or refractory acute leukemia: comparison of two different regimens.
Marit G; Cony P; Duclos F; Puntous M; Broustet A; Reiffers J
Haematol Blood Transfus; 1990; 33():614-8. PubMed ID: 2323662
[No Abstract] [Full Text] [Related]
6. [The current chemotherapy of acute myeloid leukemias in adults].
Poddubnaia IV; Perilov AA
Ter Arkh; 1993; 65(7):86-9. PubMed ID: 8211791
[No Abstract] [Full Text] [Related]
7. Intensive induction and consolidation chemotherapy in a young woman with acute myeloid leukemia and severe chronic renal failure.
Hardegger TP; von Rohr A; Tobler A; Fey MF
Ann Hematol; 1996 May; 72(5):327-8. PubMed ID: 8645746
[No Abstract] [Full Text] [Related]
8. [Acute myeloblastic leukemia 5q-. Clinical and cytogenetic remission by means of intensive chemotherapy].
Las Heras G; Ribera JM; Granada I; Millá F
Sangre (Barc); 1991 Jun; 36(3):251-2. PubMed ID: 1948550
[No Abstract] [Full Text] [Related]
9. Pneumocystis carinii pneumonia in adults with acute leukaemia: is there a need for primary chemoprophylaxis?
Lyytikäinen O; Elonen E; Lautenschlager I; Jokipii A; Tiittanen L; Ruutu P
Eur J Haematol; 1996 Mar; 56(3):188-9. PubMed ID: 8598243
[No Abstract] [Full Text] [Related]
10. Mitoxantrone.
Med Lett Drugs Ther; 1988 Jul; 30(769):67-8. PubMed ID: 3380059
[No Abstract] [Full Text] [Related]
11. Mitoxantrone and cytarabine versus daunorubicin and cytarabine in previously untreated patients with acute myeloid leukemia.
Wahlin A; Hörnsten P; Hedenus M; Malm C
Cancer Chemother Pharmacol; 1991; 28(6):480-3. PubMed ID: 1934252
[TBL] [Abstract][Full Text] [Related]
12. Remission induction and postremission therapy in acute myelogenous leukemia: British MRC Study.
Rees JK; Gray RG
Haematol Blood Transfus; 1990; 33():243-8. PubMed ID: 1691131
[No Abstract] [Full Text] [Related]
13. High-dose cytosine arabinoside and mAMSA induction and consolidation in patients with previously untreated de novo acute nonlymphocytic leukemia: Phase I Pilot Study for the Eastern Cooperative Oncology Group.
Hines JD; Mazza JJ; Oken MM; Bennett JM; Adelstein DJ; Keller A; O'Connell MJ
Semin Oncol; 1985 Jun; 12(2 Suppl 3):117-9. PubMed ID: 3839318
[No Abstract] [Full Text] [Related]
14. Combined chemotherapy with m-amsacrine in high-risk patients with acute non-lymphocytic leukemia.
Maschmeyer G; Hiddemann W; Kreutzmann H; Wendt F
Onkologie; 1987 Feb; 10(1):18-21. PubMed ID: 3295621
[TBL] [Abstract][Full Text] [Related]
15. Comparative trial of cytarabine and thioguanine in combination with amsacrine or daunorubicin in patients with untreated acute nonlymphocytic leukemia: results of the L-16M protocol.
Berman E; Arlin ZA; Gaynor J; Miller W; Gee T; Kempin SJ; Mertelsmann R; Andreeff M; Reich L; Nahmias N
Leukemia; 1989 Feb; 3(2):115-21. PubMed ID: 2911205
[TBL] [Abstract][Full Text] [Related]
16. Double intensive consolidation chemotherapy (ICC) for acute myeloid leukemia.
Harousseau JL; Milpied N; Briere J; Desablens B; Le Prise PY; Ifrah N; Gandhour C; Casassus P
Haematol Blood Transfus; 1990; 33():299-303. PubMed ID: 2323633
[No Abstract] [Full Text] [Related]
17. Comparison of results of salvage therapy in adult acute myelogenous leukemia.
Keating MJ; Estey E; Kantarjian HM; Walters R; Smith T; McCredie KB; Freireich EJ
Acta Haematol; 1987; 78 Suppl 1():120-6. PubMed ID: 3124434
[TBL] [Abstract][Full Text] [Related]
18. Amsacrine, cytarabine and thioguanine (AAT) versus daunorubicin, cytarabine, thioguanine (DAT) in adults with untreated acute non-lymphoblastic leukemia (ANLL). Austrian-German results.
Linkesch W; Michlmayr G; Gerhartz H; Illinger H; König H; Düllmann J; Keilhauer R; Moldrzyk D
Onkologie; 1989 Feb; 12(1):8-10. PubMed ID: 2654791
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance imaging follow-up in patients with acute leukemia during induction chemotherapy.
Kusnierz-Glaz C; Reiser M; Hagemeister B; Büchner T; Hiddemann W; van de Loo J
Haematol Blood Transfus; 1990; 33():351-6. PubMed ID: 2323641
[No Abstract] [Full Text] [Related]
20. [A systematic review of MA versus IA regimen for patients with acute myelogenous leukemia].
Wang WJ; Sun AN; Qiu HY
Zhonghua Xue Ye Xue Za Zhi; 2011 Dec; 32(12):869-70. PubMed ID: 22339965
[No Abstract] [Full Text] [Related]
[Next] [New Search]
